CLINICAL_TRIALS
trial_result
· 2012-08-16
Clinical Trial Update: Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus [Phase 2]
Summary
The document reports updated results from a Phase 2 expanded cohort studying bevacizumab plus everolimus in metastatic colorectal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herbert Hurwitz | Conditions: Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-16